The introduction of primary PCI significantly reduced mortality to 5.61% in patients with STEMI at HC Užice, where 88.82% received reperfusion therapy.
The establishment of a cardiac catheterization laboratory in a regional center in Serbia facilitated 8,245 procedures over a decade, achieving a 5.61% mortality rate in STEMI patients.
Tasa de eventos absoluta: 0% vs 0%
Introduction. Coronary artery disease is the most common cause of death in Serbia and worldwide. Percutaneous coronary intervention (PCI) is the optimal method of treating acute coronary syndrome in most cases. This method became available in the Health center Užice (HC) of Užice from 12.12.2011. Objective. Presentation of work in cardiac catheterization laboratory in HC Užice. Methods. This paper includes all patients who underwent coronarography, elective and primary PCI in cath lab in HC Užice in the period from 12.12.2011. to 01.07.2021. A total of 8245 patients were included, of which 1923 patients with ST elevation myocardial infarction (STEMI) and 713 patients with a non-ST elevation myocardial infarction (NSTEMI). Results. Total of 8245 procedures were performed. Out of that were 5294 diagnostic coronarography, 1291 primary PCIs, 1652 elective PCIs. The number of procedures increases by 5% per year until year 2016 and after that it was stagnant. Out of 1923 patients with STEMI, a total of 1708 (88.82%) patients received reperfusion therapy. In 67.1% of STEMI patients in primary PCI was used, and 21.7% of patients received thrombolytic therapy. Total mortality in STEMI patients was 5.61%. 79.5% of patients with NSTEMI underwent coronarography during the same hospitalization. Conclusion. Opening of cardiac catheterisation laboratory in GH Užice has improved the diagnosis and treatment of coronary disease. The introduction of primary PCI reduced the mortality of patients with STEMI. Organizing full 24/7 availability of primary PCI is still a goal that we are striving for.
Mijailović et al. (Fri,) reported a other. The introduction of primary PCI significantly reduced mortality to 5.61% in patients with STEMI at HC Užice, where 88.82% received reperfusion therapy.